Pharmacogenomics of coumarin anticoagulants: are we underestimating the role of CYP2C9?
Schalekamp
Tom
T
Maitland-van der Zee
Anke-Hilse
AH
de Boer
Anthonius
A
D000925:Anticoagulants / Q000009:adverse effects*; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics* / Q000378:metabolism; D003374:Coumarins / Q000009:adverse effects*; D065729:Cytochrome P-450 CYP2C9; D004351:Drug Resistance / Q000235:genetics*; D006470:Hemorrhage / Q000139:chemically induced / Q000235:genetics*; D006801:Humans; D010597:Pharmacogenetics; D012307:Risk Factors
D000925:Anticoagulants; D003374:Coumarins; C030123:coumarin; C450260:CYP2C9 protein, human; D065729:Cytochrome P-450 CYP2C9; D001189:Aryl Hydrocarbon Hydroxylases